Details of the Drug Therapeutic Target (DTT)
General Information of Drug Therapeutic Target (DTT) (ID: TTY3LAZ)
| DTT Name | Opioid receptor sigma 2 (PGRMC1) | ||||
|---|---|---|---|---|---|
| Synonyms | mPR; PGRMC; Membraneassociated progesterone receptor component 1; Membrane-associated progesterone receptor component 1; IZA; HPR6.6; Dap1 | ||||
| Gene Name | PGRMC1 | ||||
| DTT Type |
Literature-reported target
|
[1] | |||
| BioChemical Class |
GPCR rhodopsin
|
||||
| UniProt ID | |||||
| TTD ID | |||||
| 3D Structure | |||||
| Sequence |
MAAEDVVATGADPSDLESGGLLHEIFTSPLNLLLLGLCIFLLYKIVRGDQPAASGDSDDD
EPPPLPRLKRRDFTPAELRRFDGVQDPRILMAINGKVFDVTKGRKFYGPEGPYGVFAGRD ASRGLATFCLDKEALKDEYDDLSDLTAAQQETLSDWESQFTFKYHHVGKLLKEGEEPTVY SDEEEPKDESARKND |
||||
| Function | Binds progesterone. Has many reported cellular functions (heme homeostasis, interaction with CYPs). Component of a progesterone-binding protein complex. | ||||
| Reactome Pathway | |||||
